Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04889638 · ClinicalTrials.gov registry record · NA

Tobacco Cessation in Public Housing

A NA study of Smoking Cessation and Smoking, Tobacco, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT04889638: Completed NA study of Smoking Cessation and Smoking, Tobacco, sponsored by Johns Hopkins University.

NCT04889638 is a NA study of Smoking Cessation and Smoking, Tobacco that has completed, run by Johns Hopkins University. The registered enrollment target is 18 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04889638, a NA study of Smoking Cessation and Smoking, Tobacco, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The inequity in cessation resources is at forefront in the recently enacted nationwide smoking ban in public housing facilities. The critical component lacking from the federal decree was a practical smoking cessation strategy to address the real-world needs of active smokers who maintain cigarette usage. The investigator's proposal is ideally situated for this contemporary moment when low-income smokers in public housing are signing leases describing the potential for smoking-related evictions and thus at least contemplating smoking modification. The investigator's project is centered around the residents of Baltimore City Public Housing which is among the larger-sized U.S. public housing agencies. Using a human-centered design (HCD) approach, the investigators are refining and testing a community-centric cessation strategy defined by two core elements: a) durable and jointly linked community/hospital infrastructure systems (remote cessation specialist staffing and drug supplies) and strong on-site (public housing) residential leadership commitment to cessation improvement. These dual features, along with adaptable elements that can be modified to a variety of local/national housing settings, defines how the investigator's project will overcome the implementation gaps defining failed smoking cessation efforts in lower-income settings. The objective of this project is to test the feasibility of the intervention package among local housing contextual factors that could impact both the acceptability and adoptability of the investigator's project. Using a collection of formative and implementation evaluation measures, the investigator's academic-community partnership project is well positioned to create an adaptable and customizable intervention that can be scaled in similar housing populations.

Primary Outcome

This outcome measures assesses cravings or withdrawal that occurs upon brief cessation of smoking, smoking temptations, compulsive use, and tolerance. The scores range from 8 - 40. The lower end of the range indicates no nicotine dependence and the upper end of the range correlates with a high degree of dependence.

Interventions

  • OTHER Cessation Intervention

Study Locations (1)

Maryland

  • Creative Alternative - Baltimore

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2024-04-03
Est. Completion 2024-10-18
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT04889638 record still lists

NCT04889638 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (96% lower).

The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Cessation Intervention is the first listed.

NCT04889638 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT04889638 about?

NCT04889638 is a clinical study titled "Tobacco Cessation in Public Housing". The inequity in cessation resources is at forefront in the recently enacted nationwide smoking ban in public housing facilities. The critical component lacking from the federal decree was a practical smoking cessation strategy to address the real-world needs of active smokers who maintain cigarette ...

What is the current status of trial NCT04889638?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2024-04-03. Estimated completion is 2024-10-18.

What conditions does trial NCT04889638 study?

This clinical trial studies the following conditions: Smoking Cessation, Smoking, Tobacco, Smoking Reduction.

What interventions are being tested in trial NCT04889638?

The interventions under investigation include: Cessation Intervention (OTHER).

Who is sponsoring clinical trial NCT04889638?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04889638 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04889638's enrollment target sits among peer trials

18 180th of 188 higher than 7 of 188 other Smoking Cessation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04889638, the US trial registry maintained by the National Library of Medicine. NCT04889638 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.